Our President and Managing Director, Ms. Jennifer Che, and Principal, Ms. Pauli Wong, have been invited by the HKUST, Office of Knowledge Transfer to be speakers at the IP seminar – ‘Bright Ideas, Strong Barriers: A Patenting Masterclass’ on June 26, 2024 (Wednesday) from 15:00-16:15 at the HKUST- Chow Tak Sin Lecture Theater G (LT-G).

The seminar will be divided into two parts and focus on the following topics:

1) IP Basics, Innovation Oversight and Tips: Patent 101 and Top IP Mistakes By Start-Ups & Entrepreneurs by Ms. Pauli Wong

2) MedTech & Healthcare Hurdles: IP Challenges for Innovations in the GBA and China by Ms. Jennifer Che

This seminar is designed to enhance the understanding and awareness on IP and its significance in the academic and research fields.



我们的过去活动

Recommended Insights

China’s Newest Examination Guidelines: Post-Filing Supplemental Data for Compounds (Part I)

2021年4月28日
Post-filing data in China has been a constant issue for many patent practitioners around the world. Examiners seem to require it often, and yet the rules regarding when it is acceptable have seemed much stricter than other jurisdictions worldwide. In fact, we tried to summarize the latest state of the law in an earlier blog […]

Breaking News: Newest Draft Amendment to the Chinese Patent Law Available for Public Comment

2020年7月10日
Finally, after more than a year since the last draft amendment came out in 2019, a new draft has been submitted to the National People’s Congress Standing Committee for deliberation on June 28, 2020. The newest version is now published for public comments until August 16, 2020. As a whole, these proposed changes address a […]

China Top 10 Cases of 2020 – CNIPA Upholds Second Medical Use Patent from University of Bordeaux

2021年5月24日
The development of China’s approach to patents, especially those in the pharmaceutical and biotech space, has been fascinating to watch. Those of us who have practiced in the area for a long time have been frustrated by the Chinese patent office’s overly strict rules regarding patentability (e.g., high data support standard and refusal to consider […]

The Latest on Post-Filing Data in China’s Patent Law

2020年4月29日
Post-filing data can sometimes be the crucial difference between a patent allowance and a final rejection. The reasons are endless why important data may not have been included in the original patent application as filed. Time and budget may have been insufficient to generate data over the full scope of the claims at the time […]
Top crossarrow-right